NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK.
Curr Diab Rep. 2012 Aug;12(4):338-45. doi: 10.1007/s11892-012-0285-4.
Despite advances in screening for and treatment of diabetes, diabetic retinopathy and maculopathy are still major causes of visual loss around the world. Systematic screening programs for diabetic eye disease have been developed in many countries. The main aim of these services is to reduce diabetes-related blindness and ease the burden of illness on the patients and their families. In the United Kingdom (UK), the NHS Diabetic Eye Screening Program offers annual digital fundus photography for all patients with diabetes over the age of 12 years regardless of their socio-economic status or ethnicity. In 2010-2011 a nationwide uptake of 79% was achieved. If disease is identified, referral to a specialized eye unit for further assessment and treatment are organized to take place within a pre-specified time frame. Internal and external quality assurance ensures efficacy and safety. This paper aims to summarize the current situation of diabetic retinopathy screening in the UK and outlines the challenges ahead.
尽管在糖尿病的筛查和治疗方面取得了进展，但糖尿病性视网膜病变和黄斑病变仍然是全球视力丧失的主要原因。许多国家都制定了糖尿病眼病的系统筛查计划。这些服务的主要目的是减少与糖尿病相关的失明，并减轻患者及其家人的疾病负担。在英国 (UK)，NHS 糖尿病眼病筛查计划为所有年龄在 12 岁以上的糖尿病患者提供年度数字眼底摄影，无论其社会经济地位或种族如何。在 2010-2011 年，全国的参与率达到了 79%。如果发现疾病，将安排转介到专门的眼科单位进行进一步评估和治疗，并在规定的时间内进行。内部和外部质量保证确保了疗效和安全性。本文旨在总结英国目前的糖尿病视网膜病变筛查情况，并概述未来的挑战。
